Less Frequent Hemodialysis Prevalence and Outcomes in Australia and New Zealand

Background: Hemodialysis (HD) is initiated with three sessions per week in high-income settings with a minority starting with less frequent sessions. We aimed to evaluate prevalence, practice and outcomes of less frequent HD across Australia and New Zealand (ANZ). Methods: Adult patients starting HD in ANZ between 31st March 2004 and 31st December 2023 were categorized as either receiving less frequent HD (<3 sessions/week) or full dose HD (3 sessions/week). The primary outcome was all-cause mortality, analysed using Cox proportional hazards regression. Secondary analyses addressed prevalence and distribution of less frequent HD, cause-specific mortality, and patient and center-level characteristics associated with less frequent HD. Results: Overall, 53, 369 patients commenced HD during the study period. In total, 3,063 (6%) commenced less frequent HD, increasing over time from 3% in 2004-2008 to 11% in 2019-2023. In a multivariable model adjusted for center frailty, less frequent start HD was associated with higher all-cause mortality compared to full dose HD (HR 1.10, 95% CI 1.04-1.17, p <0.001). In adjusted Cox models, less frequent HD initiation was not associated with cause-specific mortality for cancer (HR 1.07, 95% CI 0.88-1.30, p 0.5), withdrawal (HR 1.10, 95% CI 0.98-1.23, p = 0.1), or infectious death (HR 1.02, 95% CI 0.87-1.21, p = 0.78). However, less frequent HD was associated with cardiovascular death (HR 1.20, 95% CI 1.05-1.38, p = 0.007). Conclusions: Less frequent HD practice in Australia and New Zealand is increasing over time and may be associated with higher all-cause mortality. Further large, adequately powered RCTs are warranted.

Authors

Institutions

Publication Details

Journal
Kidney360
Published
2026-11-19
DOI
https://doi.org/10.34067/kid.0000001448
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Less Frequent Hemodialysis Prevalence and Outcomes in Australia and New Zealand

Martin J. Wolley, Katharine Hegerty, Allison Tong, David Wayne Johnson et al.
Kidney360
Dialysis and Renal Disease Management
article

Less Frequent Hemodialysis Prevalence and Outcomes in Australia and New Zealand

Martin J. Wolley, Katharine Hegerty, Allison Tong, David Wayne Johnson, Ryan Gately, Andrea Katharina Viecelli, Carmel Mary Hawley
article en

Abstract

Background: Hemodialysis (HD) is initiated with three sessions per week in high-income settings with a minority starting with less frequent sessions. We aimed to evaluate prevalence, practice and outcomes of less frequent HD across Australia and New Zealand (ANZ). Methods: Adult patients starting HD in ANZ between 31st March 2004 and 31st December 2023 were categorized as either receiving less frequent HD (<3 sessions/week) or full dose HD (3 sessions/week). The primary outcome was all-cause mortality, analysed using Cox proportional hazards regression. Secondary analyses addressed prevalence and distribution of less frequent HD, cause-specific mortality, and patient and center-level characteristics associated with less frequent HD. Results: Overall, 53, 369 patients commenced HD during the study period. In total, 3,063 (6%) commenced less frequent HD, increasing over time from 3% in 2004-2008 to 11% in 2019-2023. In a multivariable model adjusted for center frailty, less frequent start HD was associated with higher all-cause mortality compared to full dose HD (HR 1.10, 95% CI 1.04-1.17, p <0.001). In adjusted Cox models, less frequent HD initiation was not associated with cause-specific mortality for cancer (HR 1.07, 95% CI 0.88-1.30, p 0.5), withdrawal (HR 1.10, 95% CI 0.98-1.23, p = 0.1), or infectious death (HR 1.02, 95% CI 0.87-1.21, p = 0.78). However, less frequent HD was associated with cardiovascular death (HR 1.20, 95% CI 1.05-1.38, p = 0.007). Conclusions: Less frequent HD practice in Australia and New Zealand is increasing over time and may be associated with higher all-cause mortality. Further large, adequately powered RCTs are warranted.

Kidney360
The University of Sydney (AU), Translational Research Institute (AU), The University of Queensland (AU), Royal Brisbane and Women's Hospital (AU), Princess Alexandra Hospital (AU), Children's Hospital at Westmead (AU), Westmead Hospital (AU), University Hospital of Zurich (CH)
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon